id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2019-0005-0007,DEA,DEA-2019-0005,Schedules of Controlled Substances: Placement of Brexanolone in Schedule IV,Rule,,2020-01-24T05:00:00Z,2020,1,2020-01-24T05:00:00Z,,2020-02-03T17:14:07Z,2020-00669,0,0,09000064842e7d87
DEA-2019-0005-0002,DEA,DEA-2019-0005,HHS Letter for Brexanolone,Supporting & Related Material,,2019-06-17T04:00:00Z,2019,6,,,2019-06-17T15:22:46Z,,0,0,0900006483d17a70
DEA-2019-0005-0003,DEA,DEA-2019-0005,Brexanolone 8-factor,Supporting & Related Material,,2019-06-17T04:00:00Z,2019,6,,,2019-06-18T11:59:49Z,,0,0,0900006483d17a71
DEA-2019-0005-0001,DEA,DEA-2019-0005,Schedules of Controlled Substances: Placement of Brexanolone in Schedule IV,Rule,,2019-06-17T04:00:00Z,2019,6,2019-06-17T04:00:00Z,2019-07-18T03:59:59Z,2019-07-17T01:01:47Z,2019-12721,0,0,0900006483d16d89